Table 2. Analysis of similarities (ANOSIM) of whole, common, and rare microbiota between disease periods.
B0 | E | T | R | B1 | |
Whole | |||||
B0 | — | 0.210 | 0.092 | 0.413 | 0.562 |
E | 0.012 | — | 0.276 | 0.177 | 0.342 |
T | 0.019 | 0.012 | — | 0.778 | 0.396 |
R | 0.001 | 0.017 | −0.034 | — | 0.199 |
B1 | −0.007 | 0.001 | 0.003 | 0.014 | — |
Common | |||||
B0 | — | 0.197 | 0.01* | 0.477 | 0.533 |
E | 0.011 | — | 0.04* | 0.208 | 0.488 |
T | 0.145 | 0.157 | — | 0.518 | 0.152 |
R | −0.005 | 0.013 | −0.008 | — | 0.140 |
B1 | −0.006 | −0.004 | 0.029 | 0.022 | — |
Rare | |||||
B0 | — | 0.123 | 0.0001* | 0.017* | 0.574 |
E | 0.027 | — | 0.0002* | 0.024* | 0.005* |
T | 0.195 | 0.152 | — | 0.0002* | 0.0001* |
R | 0.194 | 0.156 | 0.206 | — | 0.008* |
B1 | −0.007 | 0.149 | 0.194 | 0.071 | — |
ANOSIM test statistic (R) and probability (P) that two compared groups are significantly different at the P<0.05 level (denoted with asterisks) are given in the lower and upper triangles, respectively. ANOSIM R and P values were generated using the Bray–Curtis measure of similarity. Disease states are denoted by (B0) stable pre-CFPE; (E) CFPE, 30 days prior to CFPE treatment; (T) treatment for clinical exacerbation; (R) 30 days post-CFPE treatment; and (B1) stable post-CFPE.